Evidence map›Paper›PMID 38538976›Full record

ArticleAnnals of hematology2024

Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians.

Cordula Gebel, Isabel Kruschel, Steffi Bodinger, Steffen T Simon, Dennis A Eichenauer, Anne Pralong, Ulrich Wedding

Open access · hybridAbstract read
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Cordula GebelDepartment of Palliative Care, University Hospital Jena, Friedrich-Schiller University, Jena, Germany. cordula.gebel@med.uni-jena.de.ORCID http://orcid.org/0000-0002-8305-9176
Isabel KruschelDepartment of Palliative Care, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
Steffi BodingerDepartment of Palliative Care, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
Steffen T SimonDepartment of Palliative Medicine, Faculty of Medicine and Cologne University Hospital, Center for Integrated Oncology Aachen Bonn Dusseldorf Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-6884-1813
Dennis A EichenauerFirst Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Dusseldorf Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-1927-3514
Anne PralongDepartment of Palliative Medicine, Faculty of Medicine and Cologne University Hospital, Center for Integrated Oncology Aachen Bonn Dusseldorf Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-8201-2344
Ulrich WeddingDepartment of Palliative Care, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.ORCID http://orcid.org/0000-0002-0333-8643
Comprehensive Cancer Center Mainfranken · DEDüsseldorf University Hospital · DEJena University Hospital · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating palliative care into the treatment of patients with advanced hematological malignancies (HM) remains challenging. To explore treating physicians' perspectives on current palliative care practice and to evaluate factors influencing integration, we conducted a nationwide online survey. Based on literature and expert review, the survey addressed the importance of palliative care, communication about life-threatening conditions, challenges in establishing goals of care, and factors influencing the integration of palliative care. 207 physicians treating patients with HM in Germany participated. We used standard descriptive statistics to analyze quantitative data and a content structuring approach. Most physicians considered palliative care in HM to be very important (60.6%) and discussed life-threatening conditions with more than half of their patients (52%), especially when goals of care were changed (87.0%) or when patients raised the topic (84.0%). Disease-related factors, different professional perspectives on prognosis, and patient hopes were the main barriers to changing goals of care, but collaboration with colleagues and multidisciplinary teams provided important support. Time constraints were identified as the main barrier to integrating palliative care. The majority worked well with palliative care teams. Referral processes and conditions were perceived as minor barriers. The study highlights the need to address barriers to integrating palliative care into the management of patients with advanced HM. Future research should aim at optimizing palliative care for patients with HM.

Indexed as

Hematologic NeoplasmsPhysiciansTerminal CareGermanyHumansPalliative CareHematologic malignanciesIntegrationPalliative carePhysiciansReferralSurvey

Identifiers

PMID38538976
PMCPMC11009764
OpenAlexW4394738799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.